PROF(Profound Medical Corp.) · 财务报表

PROF(Profound Medical Corp.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$6.87M$6.68M$7.20M$10.68M$16.10M
毛利润$2.95M$3.02M$4.31M$7.04M$11.39M
营业利润−$30.29M−$32.13M−$28.65M−$33.06M−$41.25M
净利润−$30.70M−$28.67M−$28.32M−$27.82M−$42.57M
经营现金流−$22.36M−$25.80M−$22.61M−$23.45M−$38.21M
自由现金流−$22.39M———−$38.38M
摊薄每股收益———$1.12$1.41

Profound Medical Corp. PROF